9-133539799-G-T

Variant summary

Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong

The NM_014694.4(ADAMTSL2):​c.338G>T​(p.Arg113Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000358 in 1,398,256 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R113C) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 0.0000036 ( 0 hom. )

Consequence

ADAMTSL2
NM_014694.4 missense

Scores

9
8

Clinical Significance

Likely pathogenic criteria provided, multiple submitters, no conflicts P:3

Conservation

PhyloP100: 7.42

Publications

8 publications found
Variant links:
Genes affected
ADAMTSL2 (HGNC:14631): (ADAMTS like 2) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) and ADAMTS-like protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The protein encoded by this gene lacks the protease domain, and is therefore of a member of the the ADAMTS-like protein subfamily. It is a secreted glycoprotein that binds the cell surface and extracellular matrix; it also interacts with latent transforming growth factor beta binding protein 1. Mutations in this gene have been associated with geleophysic dysplasia. [provided by RefSeq, Feb 2009]
ADAMTSL2 Gene-Disease associations (from GenCC):
  • geleophysic dysplasia 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 14 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr9-133539798-C-T is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 1164089.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.914
PP5
Variant 9-133539799-G-T is Pathogenic according to our data. Variant chr9-133539799-G-T is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 1326072.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014694.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADAMTSL2
NM_014694.4
MANE Select
c.338G>Tp.Arg113Leu
missense
Exon 5 of 19NP_055509.2
ADAMTSL2
NM_001145320.2
c.338G>Tp.Arg113Leu
missense
Exon 5 of 19NP_001138792.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADAMTSL2
ENST00000651351.2
MANE Select
c.338G>Tp.Arg113Leu
missense
Exon 5 of 19ENSP00000498961.2
ADAMTSL2
ENST00000393061.7
TSL:1
c.665G>Tp.Arg222Leu
missense
Exon 5 of 19ENSP00000376781.3
ADAMTSL2
ENST00000354484.8
TSL:1
c.338G>Tp.Arg113Leu
missense
Exon 5 of 19ENSP00000346478.4

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD2 exomes
AF:
0.0000128
AC:
2
AN:
155946
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000808
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000358
AC:
5
AN:
1398256
Hom.:
0
Cov.:
33
AF XY:
0.00000290
AC XY:
2
AN XY:
689644
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31594
American (AMR)
AF:
0.0000560
AC:
2
AN:
35692
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25162
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35706
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79204
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48560
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5696
European-Non Finnish (NFE)
AF:
0.00000278
AC:
3
AN:
1078682
Other (OTH)
AF:
0.00
AC:
0
AN:
57960
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
34
Alfa
AF:
0.0000247
Hom.:
0

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Geleophysic dysplasia 1 Pathogenic:2
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant has been previously reported as a compound heterozygous or homozygous change in patients with geleophysic dysplasia (PMID: 27124789, 29620724). A different missense change at the same residue has also been reported in an individual with geleophysic dysplasia (PMID: 18677313). It is present in the heterozygous state in the gnomAD population database at a frequency of 0.001% (2/155946) and thus is presumed to be rare. The c.338G>T (p.Arg113Leu) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Based on the available evidence, the c.338G>T (p.Arg113Leu) variant is classified as Likely Pathogenic.

Mar 25, 2024
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Pathogenic:1
May 17, 2021
GeneDx
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27124789, 29620724, 24192049, 30415012)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.82
BayesDel_addAF
Pathogenic
0.19
D
BayesDel_noAF
Pathogenic
0.22
CADD
Pathogenic
32
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.51
D
Eigen
Pathogenic
0.88
Eigen_PC
Pathogenic
0.84
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.92
D
M_CAP
Uncertain
0.20
D
MetaRNN
Pathogenic
0.91
D
MetaSVM
Uncertain
0.15
D
PhyloP100
7.4
PrimateAI
Uncertain
0.65
T
PROVEAN
Pathogenic
-5.3
D
REVEL
Pathogenic
0.70
Sift
Uncertain
0.0040
D
Sift4G
Uncertain
0.0060
D
Polyphen
0.99
D
Vest4
0.92
MutPred
0.71
Loss of disorder (P = 0.0283)
MVP
0.91
MPC
1.4
ClinPred
0.99
D
GERP RS
5.5
Varity_R
0.62
gMVP
0.95
Mutation Taster
=9/91
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113994122; hg19: chr9-136404921; API